Neuroprotective effects of amiodarone in a mouse model of ischemic stroke

Abstract Background Ion channels play a crucial role in the development of ischemic brain injury. Recent studies have reported that the blockade of various types of ion channels improves outcomes in experimental stroke models. Amiodarone, one of the most effective drugs for life-threatening arrhythm...

Full description

Bibliographic Details
Main Authors: Masakazu Kotoda, Tadahiko Ishiyama, Kazuha Mitsui, Sohei Hishiyama, Takashi Matsukawa
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Anesthesiology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12871-017-0459-3
_version_ 1819055471273705472
author Masakazu Kotoda
Tadahiko Ishiyama
Kazuha Mitsui
Sohei Hishiyama
Takashi Matsukawa
author_facet Masakazu Kotoda
Tadahiko Ishiyama
Kazuha Mitsui
Sohei Hishiyama
Takashi Matsukawa
author_sort Masakazu Kotoda
collection DOAJ
description Abstract Background Ion channels play a crucial role in the development of ischemic brain injury. Recent studies have reported that the blockade of various types of ion channels improves outcomes in experimental stroke models. Amiodarone, one of the most effective drugs for life-threatening arrhythmia, works as a multiple channel blocker and its characteristics cover all four Vaughan-Williams classes. Although it is known that amiodarone indirectly contributes to preventing ischemic stroke by maintaining sinus rhythm in patients with atrial fibrillation, the direct neuroprotective effect of amiodarone has not been clarified. The purpose of this study was to investigate the direct effect of amiodarone on ischemic stroke in mice. Methods Focal cerebral ischemia was induced via distal permanent middle cerebral artery occlusion (MCAO) in adult male mice. The amiodarone pre-treatment group received 50 mg/kg of amiodarone 1 h before MCAO; the amiodarone post-treatment groups received 50 mg/kg of amiodarone immediately after MCAO; the control group received vehicle only. In addition, the sodium channel opener veratrine and selective beta-adrenergic agonist isoprotelenol were used to elucidate the targeted pathway. Heart rate and blood pressure were monitored perioperatively. Infarct volume analysis was conducted 48 h after MCAO. The body asymmetry test and the corner test were used for neurological evaluation. Results Amiodarone pre-treatment and post-treatment reduced the heart rate but did not affect the blood pressure. No mice showed arrhythmia. Compared with the control group, the amiodarone pre-treatment group had smaller infarct volumes (8.9 ± 2.1% hemisphere [mean ± SD] vs. 11.2 ± 1.4%; P < 0.05) and improved functional outcomes: lower asymmetric body swing rates (52 ± 17% vs. 65 ± 18%; P < 0.05) and fewer left turns (7.1 ± 1.2 vs. 8.3 ± 1.2; P < 0.05). In contrast, amiodarone post-treatment did not improve the outcomes after MCAO. The neuroprotective effect of amiodarone pre-treatment was abolished by co-administration of veratrine but not by isoproterenol. Conclusions Amiodarone pre-treatment attenuated ischemic brain injury and improved functional outcomes without affecting heart rhythm and blood pressure. The present results showed that amiodarone pre-treatment has neuroprotective effects, at least in part, via blocking the sodium channels.
first_indexed 2024-12-21T13:08:03Z
format Article
id doaj.art-ae52770fc79442f89194687c44a58ec7
institution Directory Open Access Journal
issn 1471-2253
language English
last_indexed 2024-12-21T13:08:03Z
publishDate 2017-12-01
publisher BMC
record_format Article
series BMC Anesthesiology
spelling doaj.art-ae52770fc79442f89194687c44a58ec72022-12-21T19:02:58ZengBMCBMC Anesthesiology1471-22532017-12-011711710.1186/s12871-017-0459-3Neuroprotective effects of amiodarone in a mouse model of ischemic strokeMasakazu Kotoda0Tadahiko Ishiyama1Kazuha Mitsui2Sohei Hishiyama3Takashi Matsukawa4Department of Anesthesiology, Faculty of Medicine, University of YamanashiSurgical Center, University of Yamanashi Hospital, University of YamanashiDepartment of Anesthesiology, Faculty of Medicine, University of YamanashiDepartment of Anesthesiology, Faculty of Medicine, University of YamanashiDepartment of Anesthesiology, Faculty of Medicine, University of YamanashiAbstract Background Ion channels play a crucial role in the development of ischemic brain injury. Recent studies have reported that the blockade of various types of ion channels improves outcomes in experimental stroke models. Amiodarone, one of the most effective drugs for life-threatening arrhythmia, works as a multiple channel blocker and its characteristics cover all four Vaughan-Williams classes. Although it is known that amiodarone indirectly contributes to preventing ischemic stroke by maintaining sinus rhythm in patients with atrial fibrillation, the direct neuroprotective effect of amiodarone has not been clarified. The purpose of this study was to investigate the direct effect of amiodarone on ischemic stroke in mice. Methods Focal cerebral ischemia was induced via distal permanent middle cerebral artery occlusion (MCAO) in adult male mice. The amiodarone pre-treatment group received 50 mg/kg of amiodarone 1 h before MCAO; the amiodarone post-treatment groups received 50 mg/kg of amiodarone immediately after MCAO; the control group received vehicle only. In addition, the sodium channel opener veratrine and selective beta-adrenergic agonist isoprotelenol were used to elucidate the targeted pathway. Heart rate and blood pressure were monitored perioperatively. Infarct volume analysis was conducted 48 h after MCAO. The body asymmetry test and the corner test were used for neurological evaluation. Results Amiodarone pre-treatment and post-treatment reduced the heart rate but did not affect the blood pressure. No mice showed arrhythmia. Compared with the control group, the amiodarone pre-treatment group had smaller infarct volumes (8.9 ± 2.1% hemisphere [mean ± SD] vs. 11.2 ± 1.4%; P < 0.05) and improved functional outcomes: lower asymmetric body swing rates (52 ± 17% vs. 65 ± 18%; P < 0.05) and fewer left turns (7.1 ± 1.2 vs. 8.3 ± 1.2; P < 0.05). In contrast, amiodarone post-treatment did not improve the outcomes after MCAO. The neuroprotective effect of amiodarone pre-treatment was abolished by co-administration of veratrine but not by isoproterenol. Conclusions Amiodarone pre-treatment attenuated ischemic brain injury and improved functional outcomes without affecting heart rhythm and blood pressure. The present results showed that amiodarone pre-treatment has neuroprotective effects, at least in part, via blocking the sodium channels.http://link.springer.com/article/10.1186/s12871-017-0459-3AmiodaronePre-treatmentStrokeNeuroprotection
spellingShingle Masakazu Kotoda
Tadahiko Ishiyama
Kazuha Mitsui
Sohei Hishiyama
Takashi Matsukawa
Neuroprotective effects of amiodarone in a mouse model of ischemic stroke
BMC Anesthesiology
Amiodarone
Pre-treatment
Stroke
Neuroprotection
title Neuroprotective effects of amiodarone in a mouse model of ischemic stroke
title_full Neuroprotective effects of amiodarone in a mouse model of ischemic stroke
title_fullStr Neuroprotective effects of amiodarone in a mouse model of ischemic stroke
title_full_unstemmed Neuroprotective effects of amiodarone in a mouse model of ischemic stroke
title_short Neuroprotective effects of amiodarone in a mouse model of ischemic stroke
title_sort neuroprotective effects of amiodarone in a mouse model of ischemic stroke
topic Amiodarone
Pre-treatment
Stroke
Neuroprotection
url http://link.springer.com/article/10.1186/s12871-017-0459-3
work_keys_str_mv AT masakazukotoda neuroprotectiveeffectsofamiodaroneinamousemodelofischemicstroke
AT tadahikoishiyama neuroprotectiveeffectsofamiodaroneinamousemodelofischemicstroke
AT kazuhamitsui neuroprotectiveeffectsofamiodaroneinamousemodelofischemicstroke
AT soheihishiyama neuroprotectiveeffectsofamiodaroneinamousemodelofischemicstroke
AT takashimatsukawa neuroprotectiveeffectsofamiodaroneinamousemodelofischemicstroke